Upgrade to SI Premium - Free Trial

BriaCell Therapeutics (BCTX)

3.64 +0.01 (0.28%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (10/22/26)

Latest Headlines

BriaCell's Phase 3 breast cancer study clears seventh DSMB review September 14, 2026 7:30 AM - StreetInsider Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study September 14, 2026 7:30 AM - StreetInsider Three Nasdaq Cancer Developers Under $10 Advance Clinical Programs September 11, 2026 8:45 AM - StreetInsider BriaCell adds Memorial Sloan Kettering to Phase 3 breast cancer trial September 8, 2026 7:30 AM - StreetInsider BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center September 8, 2026 7:30 AM - StreetInsider BriaCell advances melanoma vaccine candidate to genetic engineering milestone August 24, 2026 7:35 AM - StreetInsider Form 8-K BriaCell Therapeutics For: Jun 26 June 26, 2026 4:06 PM - SEC Filing Full Article List